Murphy Secures Commitment From FDA Nominee to Continue Critical Work on Sesame Labeling, Electrical Stimulation Devices on Children, Transparency
November 20, 2019
November 20, 2019
WASHINGTON, Nov. 20 -- Sen. Christopher Murphy, D-Connecticut, issued the following news release:
At the nomination hearing of Dr. Stephen M. Hahn to become the commissioner of the U.S. Food & Drug Administration (FDA), U.S. Senator Chris Murphy (D-Conn.), a member of the U.S. Senate Health, Education, Labor and Pensions Committee, questioned Dr. Hahn on his priorities if confirmed to be the next commissioner of the FDA. During his questions, Murphy secured a verbal commitment f . . .
At the nomination hearing of Dr. Stephen M. Hahn to become the commissioner of the U.S. Food & Drug Administration (FDA), U.S. Senator Chris Murphy (D-Conn.), a member of the U.S. Senate Health, Education, Labor and Pensions Committee, questioned Dr. Hahn on his priorities if confirmed to be the next commissioner of the FDA. During his questions, Murphy secured a verbal commitment f . . .